Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:GUJTHEM
Clear all filters
NEWS
positive
Business Standard - Markets 47d ago

Gujarat Themis Biosyn jumps on acquisition of Japan-based MicroBiopharm

Gujarat Themis Biosyn surged 6.11% to Rs 391.40 after the company announced the acquisition of Japan-based MicroBiopharm Japan Co. (MBJ) for about JPY 21.5 billion, or nearly Rs 1,300 crore.

GUJTHEMHealthcare
Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore
positive
CNBC TV18 - Markets 49d ago

Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore

Shares of Gujarat Themis Biosyn Ltd ended at ₹364.50, up by ₹7.40, or 2.07%, on the BSE.

BSEGUJTHEMFinancial ServicesHealthcare
Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma, Hindalco, Eicher Motors, Divis Labs, NTPC in focus on 25 May
positive
Moneycontrol NaNd ago

Stocks to Watch Today: TVS Motor, Exide Industries, Meesho, Groww, Gujarat Themis, Glenmark Pharma, Hindalco, Eicher Motors, Divis Labs, NTPC in focus on 25 May

Stocks to Watch, 25 May: Stocks like NTPC, Hindalco Industries, Eicher Motors, Torrent Pharmaceuticals, Colgate Palmolive India, Divis Laboratories, Tata Capital, Lenskart Solutions, LG Electronics, Meesho, ICICI Prudential AMC, and Billionbrains Garage Ventures Groww will be in focus on May 28.

AKCAPITALPL30IETFAUTOIETFBANKIETFBSE500IETFCASHIETFCOLPALCOMMOIETFCONSUMIETFCPCAPEICHERMOTEVIETFEXIDEINDFINIETFFMCGIETFFOCUSGLENMARKGOLDIETFGROWWGROWWCAPMGSEC10IETFGSEC5IETFGUJTHEMHEALTHIETFHINDALCOICICIAMCICICIB22ICICIPRULIINFRAIETFITIETFLENSKARTLGEINDIALIQUIDIETFLOWVOLIETFMEESHOMETALIETFMIDCAPIETFMIDSELIETFMOM30IETFNEXT50IETFNIF100IETFNIFTYIETFNTPCNV20IETFOILIETFPSUBNKIETFPVTBANIETFQUAL30IETFSENSEXIETFSILVERIETFTATACAPTATATECHTMCVTMPVTOP15IETFTORNTPHARMTVSELECTTVSHLTDTVSMOTORVAL30IETFAutomobile and Auto ComponentsCapital Goods
Gujarat Themis Biosyn in focus after Rs 1,300 crore acquisition deal for Japanese firm
positive
Moneycontrol NaNd ago

Gujarat Themis Biosyn in focus after Rs 1,300 crore acquisition deal for Japanese firm

Gujarat Themis Biosyn Share Price | The company announced the acquisition of 100% stake in MicroBiopharm Japan Co., Ltd. for JPY 21.5 billion (around ₹1,300 crore).

FOCUSGUJTHEMConsumer DurablesHealthcare